| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |